Results 61 to 70 of about 233,946 (332)

Prevention of the post thrombotic syndrome with anticoagulation: a narrative review

open access: yesThrombosis and Haemostasis, 2021
The post thrombotic syndrome (PTS) is chronic venous insufficiency secondary to a prior deep vein thrombosis (DVT). It is the most common complication of VTE and, while not fatal, it can lead to chronic, unremitting symptoms as well as societal and ...
I. Makedonov   +6 more
semanticscholar   +1 more source

Hybrid CT-angiography to facilitate lower extremity sharp venous recanalization: a novel approach to a common procedure

open access: yesCVIR Endovascular, 2020
Background Post-thrombotic syndrome due to chronic venous occlusion is associated with high morbidity and healthcare costs. Sharp venous recanalization has been used with success when conventional techniques fail to cross the occlusion, permitting ...
Monica M. Matsumoto   +4 more
doaj   +1 more source

The post-thrombotic syndrome - a condition to prevent

open access: yesDermatology Online Journal, 2008
The incidence of the post-thrombotic syndrome (PTS) is increasing along with the incidence of deep vein thrombosis (DVT). The overall frequency of PTS ranges from 20 percent to 50 percent of DVT patients; severe PTS, which includes leg ulcers, occurs in a quarter of cases.
Pirard, Delphine   +2 more
openaire   +5 more sources

Scoring systems for the post-thrombotic syndrome [PDF]

open access: yesJournal of Vascular Surgery, 2013
To assess each of the scoring systems used to diagnose and classify post-thrombotic syndrome, a common chronic complication of deep vein thrombosis. The design of the study was a systematic review of the literature pertaining to post-thrombotic syndrome.A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews ...
Soosainathan, Arany   +3 more
openaire   +2 more sources

Post‐thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long‐term cross‐sectional follow‐up of RE‐COVER study patients

open access: yesJournal of Thrombosis and Haemostasis, 2021
Studies suggest that the direct factor Xa inhibitor rivaroxaban compared to warfarin reduces the risk of post‐thrombotic syndrome (PTS) after deep vein thrombosis (DVT), but this has not been evaluated for oral direct thrombin inhibitors.
H. Wik   +6 more
semanticscholar   +1 more source

Is there a role for oral triple therapy in patients with acute coronary syndromes without atrial fibrillation? [PDF]

open access: yes, 2018
© 2018 Bentham Science PublishersBACKGROUND: Acute coronary syndrome (ACS) patients, despite treatment with dual antiplatelet therapy (DAPT), have up to 10% risk of recurrent major adverse cardiac events (MACE) in the short term.
Akhtar, Zaki   +3 more
core   +2 more sources

Prevention and treatment of the post‐thrombotic syndrome

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2018
Post thrombotic syndrome (PTS) is a common chronic complication of deep vein thrombosis of the leg (DVT). Treatment options are limited therefore emphasis is placed on its prevention. Several risk factors have been recognized, but were so far not used for risk stratification or translation into prediction models.
Oleg, Pikovsky, Anat, Rabinovich
openaire   +5 more sources

Acute phase determinant of post-thrombotic syndrome: A review of the literature.

open access: yesThrombosis Research
BACKGROUND Post-thrombotic syndrome (PTS) is the main long-term complication of deep vein thrombosis (DVT). Several therapies are being evaluated to prevent or to treat PTS.
L. Khider   +8 more
semanticscholar   +1 more source

Predictors for the Risk and Severity of Post Thrombotic Syndrome in Vascular Behcet's Disease.

open access: yesJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2021
OBJECTIVES Deep venous thrombosis (DVT) of the lower extremities (LE) is the most common form of vascular involvement in Behçet's disease (BD), leading frequently to post-thrombotic syndrome (PTS) as a disabling complication.
A. Aksoy   +16 more
semanticscholar   +1 more source

Vascular miR‐181b controls tissue factor‐dependent thrombogenicity and inflammation in type 2 diabetes [PDF]

open access: yes, 2020
BACKGROUND: Diabetes mellitus is characterized by chronic vascular inflammation leading to pathological expression of the thrombogenic full length (fl) tissue factor (TF) and its isoform alternatively-spliced (as) TF. Blood-borne TF promotes factor (
Chakraborty, Aritra   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy